259 related articles for article (PubMed ID: 27587010)
21. Changes in Direct Healthcare Costs before and after the Diagnosis of Inflammatory Bowel Disease: A Nationwide Population-Based Study.
Lee J; Im JP; Han K; Kim J; Lee HJ; Chun J; Kim JS
Gut Liver; 2020 Jan; 14(1):89-99. PubMed ID: 31158951
[No Abstract] [Full Text] [Related]
22. Cost of outpatient care in patients with inflammatory bowel disease in a German University Hospital.
Ebinger M; Leidl R; Thomas S; Von Tirpitz C; Reinshagen M; Adler G; Konig HH
J Gastroenterol Hepatol; 2004 Feb; 19(2):192-9. PubMed ID: 14731130
[TBL] [Abstract][Full Text] [Related]
23. Direct medical cost of managing IBD patients: a Canadian population-based study.
Bernstein CN; Longobardi T; Finlayson G; Blanchard JF
Inflamm Bowel Dis; 2012 Aug; 18(8):1498-508. PubMed ID: 22109958
[TBL] [Abstract][Full Text] [Related]
24. Mental Health Costs of Inflammatory Bowel Diseases.
Szigethy E; Murphy SM; Ehrlich OG; Engel-Nitz NM; Heller CA; Henrichsen K; Lawton R; Meadows P; Allen JI
Inflamm Bowel Dis; 2021 Jan; 27(1):40-48. PubMed ID: 32095835
[TBL] [Abstract][Full Text] [Related]
25. Cost Burden of Crohn's Disease and Ulcerative Colitis in the 10-Year Period Before Diagnosis-A Danish Register-Based Study From 2003-2015.
Vadstrup K; Alulis S; Borsi A; Gustafsson N; Nielsen A; Wennerström ECM; Jørgensen TR; Qvist N; Munkholm P
Inflamm Bowel Dis; 2020 Aug; 26(9):1377-1382. PubMed ID: 31693731
[TBL] [Abstract][Full Text] [Related]
26. [Cost of early management of chronic inflammatory intestinal disease].
Rolland N; Grandbastien B; Merle V; Gower-Rousseau C; Yzet T; Marti R; Lerebours E; Dupas JL; Czernichow P; Salomez JL; Lebrun T; Cortot A
Gastroenterol Clin Biol; 1999 Apr; 23(4):483-8. PubMed ID: 10416112
[TBL] [Abstract][Full Text] [Related]
27. A Phenome-Wide Analysis of Healthcare Costs Associated with Inflammatory Bowel Diseases.
Cai W; Cagan A; He Z; Ananthakrishnan AN
Dig Dis Sci; 2021 Mar; 66(3):760-767. PubMed ID: 32436120
[TBL] [Abstract][Full Text] [Related]
28. Biological therapy in inflammatory bowel diseases: access in Central and Eastern Europe.
Rencz F; Péntek M; Bortlik M; Zagorowicz E; Hlavaty T; Śliwczyński A; Diculescu MM; Kupcinskas L; Gecse KB; Gulácsi L; Lakatos PL
World J Gastroenterol; 2015 Feb; 21(6):1728-37. PubMed ID: 25684937
[TBL] [Abstract][Full Text] [Related]
29. Indirect health costs in ulcerative colitis and Crohn's disease: a systematic review and meta-analysis.
Kawalec P; Malinowski KP
Expert Rev Pharmacoecon Outcomes Res; 2015 Apr; 15(2):253-66. PubMed ID: 25656310
[TBL] [Abstract][Full Text] [Related]
30. Inflammatory bowel disease: costs-of-illness.
Hay JW; Hay AR
J Clin Gastroenterol; 1992 Jun; 14(4):309-17. PubMed ID: 1607607
[TBL] [Abstract][Full Text] [Related]
31. Resource use and cost of care with biologicals in Crohn's disease in South Africa: a retrospective analysis from a payer perspective.
Miot J; Smith S; Bhimsan N
Int J Clin Pharm; 2016 Aug; 38(4):880-7. PubMed ID: 27118462
[TBL] [Abstract][Full Text] [Related]
32. Higher levels of knowledge reduce health care costs in patients with inflammatory bowel disease.
Colombara F; Martinato M; Girardin G; Gregori D
Inflamm Bowel Dis; 2015 Mar; 21(3):615-22. PubMed ID: 25636120
[TBL] [Abstract][Full Text] [Related]
33. Inflammatory bowel disease: medical cost algorithms.
Hay AR; Hay JW
J Clin Gastroenterol; 1992 Jun; 14(4):318-27. PubMed ID: 1607608
[TBL] [Abstract][Full Text] [Related]
34. The Crohn's and Colitis Foundation of America Survey of Inflammatory Bowel Disease Patient Health Care Access.
Rubin DT; Feld LD; Goeppinger SR; Margolese J; Rosh J; Rubin M; Kim S; Rodriquez DM; Wingate L
Inflamm Bowel Dis; 2017 Feb; 23(2):224-232. PubMed ID: 27997434
[TBL] [Abstract][Full Text] [Related]
35. The direct and indirect cost burden of Crohn's disease and ulcerative colitis.
Gibson TB; Ng E; Ozminkowski RJ; Wang S; Burton WN; Goetzel RZ; Maclean R
J Occup Environ Med; 2008 Nov; 50(11):1261-72. PubMed ID: 19001952
[TBL] [Abstract][Full Text] [Related]
36. Telemonitoring of Crohn's Disease and Ulcerative Colitis (TECCU): Cost-Effectiveness Analysis.
Del Hoyo J; Nos P; Bastida G; Faubel R; Muñoz D; Garrido-Marín A; Valero-Pérez E; Bejar-Serrano S; Aguas M
J Med Internet Res; 2019 Sep; 21(9):e15505. PubMed ID: 31538948
[TBL] [Abstract][Full Text] [Related]
37. Health care costs and their predictors of inflammatory bowel diseases in Germany.
Prenzler A; Bokemeyer B; von der Schulenburg JM; Mittendorf T
Eur J Health Econ; 2011 Jun; 12(3):273-83. PubMed ID: 20967482
[TBL] [Abstract][Full Text] [Related]
38. Prevalence of inflammatory bowel disease in an insured population in Puerto Rico during 1996.
Torres EA; De Jesús R; Pérez CM; Iñesta M; Torres D; Morell C; Just E
P R Health Sci J; 2003 Sep; 22(3):253-8. PubMed ID: 14619451
[TBL] [Abstract][Full Text] [Related]
39. [Analysis of total cost of treatment of patients with inflammatory bowel diseases].
Lazebnik LB; Parfenov AI; Guseĭnzade MG; Kniazev OV; Efremov LI
Eksp Klin Gastroenterol; 2011; (5):3-7. PubMed ID: 21919238
[TBL] [Abstract][Full Text] [Related]
40. Health Care Cost Analysis in a Population-based Inception Cohort of Inflammatory Bowel Disease Patients in the First Year of Diagnosis.
Niewiadomski O; Studd C; Hair C; Wilson J; McNeill J; Knight R; Prewett E; Dabkowski P; Dowling D; Alexander S; Allen B; Tacey M; Connell W; Desmond P; Bell S
J Crohns Colitis; 2015 Nov; 9(11):988-96. PubMed ID: 26129692
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
